Source: BBC News
Summary
Young women vaccinated against HPV at ages 12-13 now face nearly zero risk of dying from cervical cancer. This significant breakthrough highlights the effectiveness of early vaccination in preventing this deadly disease.
Why It Matters
The HPV vaccine represents a major advancement in public health, significantly reducing the mortality rate associated with cervical cancer. Vaccinating young girls ensures long-term protection, ultimately leading to healthier futures and reduced healthcare costs related to cancer treatments. This finding reinforces the importance of vaccination programs globally.






